CDKI-73

CAS: 1421693-22-2

Ref. 3D-WGC69322

Produktinformation

• Name: CDKI-73
• CAS: 1421693-22-2

Beschreibung

CDKI-73 is a potent antiproliferative agent that inhibits protein synthesis, leading to cancer cell death. CDKI-73 can be administered orally and has been shown to have predictive biomarker properties in chronic lymphocytic leukemia (CLL). CDKI-73 induces apoptotic cell death by inhibiting the production of pro-inflammatory cytokines, such as TNFα and IL-1β. CDKI-73 also induces leukemic stem cells to undergo apoptotic cell death. CDKI-73 binds to and cleaves the antimicrobial peptide LL37, which may lead to its therapeutic effects.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 394.45 g/mol
• Formel: C₁₅H₁₅FN₆O₂S₂
• Reinheit: Min. 95%